Jose “Pepe” Alvarez, Jr., M.D. Memorial Lecture on Vascular Disease Evaluation - May 8, 2018

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1	The information and/or skills learned will enhance my professional competence or ability. - 0
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 0

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease.	Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease. - 5	Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease. - 4	Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease. - 3	Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease. - 2	Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease. - 1	Discuss the indications and outcomes for the use of endovascular therapy for the treatment of complex aortic disease. - 0
Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks.	Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks. - 5	Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks. - 4	Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks. - 3	Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks. - 2	Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks. - 1	Assess the risks associated with the use of endovascular therapy to treat complex aortic disease and modifications to the clinical approach that can be used to mitigate these risks. - 0
Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease.	Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease. - 5	Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease. - 4	Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease. - 3	Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease. - 2	Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease. - 1	Recognize the limitations and potential expansion of future endovascular therapy to treat complex aortic disease. - 0

Rate the following *

Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

	5	4	3	2	1
Course content.	Course content. - 5	Course content. - 4	Course content. - 3	Course content. - 2	Course content. - 1
Matthew J. Eagleton, M.D.	Matthew J. Eagleton, M.D. - 5	Matthew J. Eagleton, M.D. - 4	Matthew J. Eagleton, M.D. - 3	Matthew J. Eagleton, M.D. - 2	Matthew J. Eagleton, M.D. - 1

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Please list specific changes you intend to implement in your daily practice as a result of attending this activity. *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. *

List topics related to this lecture that you want to learn more about?

Comments

Name

Leave this field blank

You are here

Jose “Pepe” Alvarez, Jr., M.D. Memorial Lecture on Vascular Disease Evaluation - May 8, 2018